Spruce Biosciences's market cap is currently ―. The company's EPS TTM is $-1.263; its P/E ratio is -0.56; Spruce Biosciences is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	$ 2.20M	$ 2.00M	-	$ 0.00	$ 0.00
Gross Profit	$ 2.20M	$ 2.00M	-	-	-
EBIT	$ -12.66M	$ -13.16M	$ -12.27M	$ -11.29M	$ -11.78M
EBITDA	-	$ -13.33M	$ -12.24M	$ -11.27M	$ -11.77M
Net Income Common Stockholders	$ -12.79M	$ -12.76M	$ -11.14M	$ -11.40M	$ -11.87M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 120.52M	$ 118.58M	$ 79.08M	$ 90.40M	$ 93.30M
Total Assets	$ 125.96M	$ 139.11M	$ 85.65M	$ 95.30M	$ 104.52M
Total Debt	$ 4.13M	$ 4.52M	$ 6.18M	$ 6.29M	$ 6.37M
Net Debt	$ -116.39M	$ -114.06M	$ -72.90M	$ -84.11M	$ -86.93M
Total Liabilities	$ 29.40M	$ 31.11M	$ 17.16M	$ 16.82M	$ 15.39M
Stockholders Equity	$ 96.56M	$ 108.00M	$ 68.49M	$ 78.47M	$ 89.12M
Cash Flow	-
Free Cash Flow	-	$ -11.79M	$ -11.74M	$ -8.58M	$ -9.55M
Operating Cash Flow	$ 1.99M	$ -11.79M	$ -11.74M	$ -8.58M	$ -9.54M
Investing Cash Flow	$ 22.00M	$ 10.48M	$ 14.57M	$ -16.89M	$ 33.51M
Financing Cash Flow	$ -432.00K	$ 50.53M	$ 36.00K	$ -90.00K	$ -99.00K

Currency in USD

Spruce Biosciences Earnings and Revenue History

Income Statement >

Spruce Biosciences Debt to Assets

Balance Sheet >

Spruce Biosciences Cash Flow

Cash Flow >

Spruce Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing